Seasonal influenza vaccine uptake among patients with cardiovascular disease in Denmark, 2017-2019

Daniel Molager Christensen; Sidsel Marie Bernt Jorgensen; Mohamad El-Chouli; Matthew Phelps; Anne-Marie Schjerning; Thomas S. G. Sehested; Thomas Gerds; Caroline Sindet-Pedersen; Tor Biering-Sorensen; Christian Torp-Pedersen; Morten Schou; Gunnar Gislason

doi:10.1093/ehjqcco/qcac049

Seasonal influenza vaccine uptake among patients with cardiovascular disease in Denmark, 2017-2019

Daniel Molager Christensen^*, Sidsel Marie Bernt Jorgensen, Mohamad El-Chouli, Matthew Phelps^*, Anne-Marie Schjerning, Thomas S. G. Sehested, Thomas Gerds, Caroline Sindet-Pedersen, Tor Biering-Sorensen, Christian Torp-Pedersen, Morten Schou, Gunnar Gislason

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

4 Citationer (Scopus)

19 Downloads (Pure)

Abstract

Background Influenza vaccination protects against morbidity and mortality in patients with cardiovascular disease (CVD). We aimed to describe influenza vaccine uptake in patients with CVD in a universal-access healthcare system. Methods Using nationwide Danish registries, we included all patients with prevalent CVD, defined as heart failure (HF), atrial fibrillation (AF), ischemic heart disease (IHD), or stroke during three consecutive influenza seasons (October-December 2017-2019). The outcome was relative frequency of influenza vaccination across strata of patient characteristics. Results There was an average of 397 346 patients with CVD yearly during 2017-2019. Vaccine uptake was 45.6% for the whole population and ranged from 55.0% in AF to 61.8% in HF among patients aged >= 65 years. Among patients aged

Originalsprog	Engelsk
Tidsskrift	European Heart Journal - Quality of Care and Clinical Outcomes
Vol/bind	9
Udgave nummer	4
Sider (fra-til)	474–481
Antal sider	8
ISSN	2058-5225
DOI	https://doi.org/10.1093/ehjqcco/qcac049
Status	Udgivet - 2023

Adgang til dokumentet

10.1093/ehjqcco/qcac049Licens: CC BY-NC

FulltextForlagets udgivne version, 915 KBLicens: CC BY-NC

Citationsformater

Christensen, D. M., Bernt Jorgensen, S. M., El-Chouli, M., Phelps, M., Schjerning, A.-M., Sehested, T. S. G., Gerds, T., Sindet-Pedersen, C., Biering-Sorensen, T., Torp-Pedersen, C., Schou, M., & Gislason, G. (2023). Seasonal influenza vaccine uptake among patients with cardiovascular disease in Denmark, 2017-2019. European Heart Journal - Quality of Care and Clinical Outcomes, 9(4), 474–481. https://doi.org/10.1093/ehjqcco/qcac049

Seasonal influenza vaccine uptake among patients with cardiovascular disease in Denmark, 2017-2019. / Christensen, Daniel Molager; Bernt Jorgensen, Sidsel Marie; El-Chouli, Mohamad et al.
I: European Heart Journal - Quality of Care and Clinical Outcomes, Bind 9, Nr. 4, 2023, s. 474–481.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Christensen, DM, Bernt Jorgensen, SM, El-Chouli, M, Phelps, M, Schjerning, A-M, Sehested, TSG, Gerds, T, Sindet-Pedersen, C, Biering-Sorensen, T , Torp-Pedersen, C , Schou, M & Gislason, G 2023, 'Seasonal influenza vaccine uptake among patients with cardiovascular disease in Denmark, 2017-2019', European Heart Journal - Quality of Care and Clinical Outcomes, bind 9, nr. 4, s. 474–481. https://doi.org/10.1093/ehjqcco/qcac049

@article{b09fe125534841bc981bc15ee8bc14e3,

title = "Seasonal influenza vaccine uptake among patients with cardiovascular disease in Denmark, 2017-2019",

abstract = "Background Influenza vaccination protects against morbidity and mortality in patients with cardiovascular disease (CVD). We aimed to describe influenza vaccine uptake in patients with CVD in a universal-access healthcare system. Methods Using nationwide Danish registries, we included all patients with prevalent CVD, defined as heart failure (HF), atrial fibrillation (AF), ischemic heart disease (IHD), or stroke during three consecutive influenza seasons (October-December 2017-2019). The outcome was relative frequency of influenza vaccination across strata of patient characteristics. Results There was an average of 397 346 patients with CVD yearly during 2017-2019. Vaccine uptake was 45.6% for the whole population and ranged from 55.0% in AF to 61.8% in HF among patients aged >= 65 years. Among patients aged",

keywords = "Influenza, Vaccine, Cardiovascular, Registry, SECONDARY PREVENTION, EVENTS, ADULTS",

author = "Christensen, {Daniel Molager} and {Bernt Jorgensen}, {Sidsel Marie} and Mohamad El-Chouli and Matthew Phelps and Anne-Marie Schjerning and Sehested, {Thomas S. G.} and Thomas Gerds and Caroline Sindet-Pedersen and Tor Biering-Sorensen and Christian Torp-Pedersen and Morten Schou and Gunnar Gislason",

year = "2023",

doi = "10.1093/ehjqcco/qcac049",

language = "English",

volume = "9",

pages = "474–481",

journal = "European Heart Journal - Quality of Care and Clinical Outcomes",

issn = "2058-5225",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - Seasonal influenza vaccine uptake among patients with cardiovascular disease in Denmark, 2017-2019

AU - Christensen, Daniel Molager

AU - Bernt Jorgensen, Sidsel Marie

AU - El-Chouli, Mohamad

AU - Phelps, Matthew

AU - Schjerning, Anne-Marie

AU - Sehested, Thomas S. G.

AU - Gerds, Thomas

AU - Sindet-Pedersen, Caroline

AU - Biering-Sorensen, Tor

AU - Torp-Pedersen, Christian

AU - Schou, Morten

AU - Gislason, Gunnar

PY - 2023

Y1 - 2023

N2 - Background Influenza vaccination protects against morbidity and mortality in patients with cardiovascular disease (CVD). We aimed to describe influenza vaccine uptake in patients with CVD in a universal-access healthcare system. Methods Using nationwide Danish registries, we included all patients with prevalent CVD, defined as heart failure (HF), atrial fibrillation (AF), ischemic heart disease (IHD), or stroke during three consecutive influenza seasons (October-December 2017-2019). The outcome was relative frequency of influenza vaccination across strata of patient characteristics. Results There was an average of 397 346 patients with CVD yearly during 2017-2019. Vaccine uptake was 45.6% for the whole population and ranged from 55.0% in AF to 61.8% in HF among patients aged >= 65 years. Among patients aged

AB - Background Influenza vaccination protects against morbidity and mortality in patients with cardiovascular disease (CVD). We aimed to describe influenza vaccine uptake in patients with CVD in a universal-access healthcare system. Methods Using nationwide Danish registries, we included all patients with prevalent CVD, defined as heart failure (HF), atrial fibrillation (AF), ischemic heart disease (IHD), or stroke during three consecutive influenza seasons (October-December 2017-2019). The outcome was relative frequency of influenza vaccination across strata of patient characteristics. Results There was an average of 397 346 patients with CVD yearly during 2017-2019. Vaccine uptake was 45.6% for the whole population and ranged from 55.0% in AF to 61.8% in HF among patients aged >= 65 years. Among patients aged

KW - Influenza

KW - Vaccine

KW - Cardiovascular

KW - Registry

KW - SECONDARY PREVENTION

KW - EVENTS

KW - ADULTS

U2 - 10.1093/ehjqcco/qcac049

DO - 10.1093/ehjqcco/qcac049

M3 - Journal article

C2 - 35953403

SN - 2058-5225

VL - 9

SP - 474

EP - 481

JO - European Heart Journal - Quality of Care and Clinical Outcomes

JF - European Heart Journal - Quality of Care and Clinical Outcomes

IS - 4

ER -